Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

18794 - Human Photo Toxicity Test

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02751372
Recruitment Status : Completed
First Posted : April 26, 2016
Last Update Posted : December 13, 2018
Sponsor:
Information provided by (Responsible Party):
Bayer

Brief Summary:
To determine the phototoxic potential of a topically applied article in human subjects.

Condition or disease Intervention/treatment Phase
Sunscreening Agents Drug: BAY 987517 Other: Untreated Skin Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 35 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Human Phototoxicity Test
Actual Study Start Date : May 2, 2016
Actual Primary Completion Date : May 6, 2016
Actual Study Completion Date : May 6, 2016

Arm Intervention/treatment
Experimental: BAY 987517
All subjects are patched .
Drug: BAY 987517
50 μl/cm*2 or 0.05 gm/cm*2 of each test product is applied to duplicate skin sites (approximately 2 x 2 cm each). After the test articles have dried for 5 to 15 min, the sites are covered by the appropriate patch.24 hours later, the set of patches covering the product are removed. Three (3) μl/ cm2 or 0.003 gm/cm*2 of the test product is reapplied to the test site, air dried for 5 to 15 minutes for volatilization and then the test site is exposed to UVA radiation.

Other: Untreated Skin
This site is patched without treatment as irradiated control




Primary Outcome Measures :
  1. Intensity of skin reactions will be evaluated using 5 point grading scale [ Time Frame: Up to 48 hours ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Be male or female between the ages of 18 and 60 inclusive;
  • Be lightly pigmented (Fitzpatrick Skin Type I, II, III);
  • Have read and signed the written Informed Consent Form and have completed a HIPAA Authorization Form in conformance with 45CFR Parts 160 and 164;
  • Be in general good health as determined by the subject's medical history and in the discretion of the investigator.

Exclusion Criteria:

  • Have a visible sunburn;
  • Have a history of sun hypersensitivity/photosensitivity or photosensitive dermatoses;
  • Must not have a known sensitivity or allergy against any of the active and non-active ingredients of the test product.
  • Have a history of allergies or sensitivities to cosmetics, toiletries or any dermatological products.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02751372


Locations
Layout table for location information
United States, New Jersey
Piscataway, New Jersey, United States, 08854
Sponsors and Collaborators
Bayer
Investigators
Layout table for investigator information
Study Director: Bayer Study Director Bayer

Additional Information:
Layout table for additonal information
Responsible Party: Bayer
ClinicalTrials.gov Identifier: NCT02751372     History of Changes
Other Study ID Numbers: 18794
First Posted: April 26, 2016    Key Record Dates
Last Update Posted: December 13, 2018
Last Verified: December 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No